This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

4 Stocks Dragging In The Real Estate Industry

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Two out of the three major indices are trading lower today with the
Dow Jones Industrial Average (
^DJI) trading down 40 points (-0.3%) at 14,679 as of Wednesday, April 24, 2013, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,751 issues advancing vs. 1,159 declining with 143 unchanged.

TheStreet Ratings group would like to highlight 4 stocks pushing the industry lower today:

4.
Sabra Health Care REIT (
SBRA) is one of the companies pushing the Real Estate industry lower today. As of noon trading, Sabra Health Care REIT is down $1.35 (-4.4%) to $29.35 on average volume Thus far, 171,503 shares of Sabra Health Care REIT exchanged hands as compared to its average daily volume of 241,600 shares. The stock has ranged in price between $29.34-$30.20 after having opened the day at $29.86 as compared to the previous trading day's close of $30.70.

Sabra Health Care REIT, Inc. operates as a real estate investment trust in the United States. The company, through its subsidiaries, owns and invests in real estate properties for the healthcare industry. Sabra Health Care REIT has a market cap of $1.1 billion and is part of the financial sector. The company has a P/E ratio of 58.2, above the S&P 500 P/E ratio of 17.7. Shares are up 41.3% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Sabra Health Care REIT as a
sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow. Get the full
Sabra Health Care REIT Ratings Report now.